Literature DB >> 28555473

Epidemiological aspects and spatial distribution of human and canine visceral leishmaniasis in an endemic area in northeastern Brazil.

Roseane Campos1, Márcio Santos, Gabriel Tunon, Luana Cunha, Lucas Magalhães, Juliana Moraes, Danielle Ramalho, Sanmy Lima, José Antônio Pacheco, Michael Lipscomb, Amélia Ribeiro de Jesus, Roque Pacheco de Almeida.   

Abstract

Visceral leishmaniasis (VL) is a systemic disease endemic in tropical countries and transmitted through sand flies. In particular, Canis familiaris (or domesticated dogs) are believed to be a major urban reservoir for the parasite causing the disease Leishmania. The average number of human VL cases was 58 per year in the state of Sergipe. The city of Aracaju, capital of Sergipe in Northeastern Brazil, had 159 cases of VL in humans. Correlatively, the percentage of serologically positive dogs for leishmaniasis increased from 4.73% in 2008 to 12.69% in 2014. Thus, these studies aimed to delineate the spatial distribution and epidemiological aspects of human and canine VL as mutually supportive for increased incidence. The number of human cases of VL and the frequency of canine positive serology for VL both increased between 2008 and 2014. Spatial distribution analyses mapped areas of the city with the highest concentration of human and canine VL cases. The neighbourhoods that showed the highest disease frequency were located on the outskirts of the city and in urbanised areas or subjected to development. Exponential increase in VL-positive dogs further suggests that the disease is expanding in urban areas, where it can serve as a reservoir for transmission of dogs to humans via the sand fly vector.

Entities:  

Mesh:

Year:  2017        PMID: 28555473     DOI: 10.4081/gh.2017.503

Source DB:  PubMed          Journal:  Geospat Health        ISSN: 1827-1987            Impact factor:   1.212


  6 in total

1.  Increased thiol levels in antimony-resistant Leishmania infantum isolated from treatment-refractory visceral leishmaniasis in Brazil.

Authors:  Lucas S Magalhães; Lays Gs Bomfim; Sthefanne G Mota; Geydson S Cruz; Cristiane B Corrêa; Diego M Tanajura; Michael W Lipscomb; Valéria M Borges; Amélia R de Jesus; Roque P de Almeida; Tatiana R de Moura
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-02       Impact factor: 2.743

2.  Space-time risk cluster of visceral leishmaniasis in Brazilian endemic region with high social vulnerability: An ecological time series study.

Authors:  Caique J N Ribeiro; Allan D Dos Santos; Shirley V M A Lima; Eliete R da Silva; Bianca V S Ribeiro; Andrezza M Duque; Marcus V S Peixoto; Priscila L Dos Santos; Iris M de Oliveira; Michael W Lipscomb; Karina C G M de Araújo; Tatiana R de Moura
Journal:  PLoS Negl Trop Dis       Date:  2021-01-19

3.  Canine Leishmaniasis in an Endemic Area for Human Leishmaniasis in Nicaragua.

Authors:  Byron Flores; Brenda Mora-Sánchez; Dayana Torres; Jessica Sheleby-Elías; William Jirón; José Luis Balcazar
Journal:  J Trop Med       Date:  2022-08-29

Review 4.  Factors associated with the expansion of leishmaniasis in urban areas: a systematic and bibliometric review (1959-2021).

Authors:  Marília Schutz Borges; Luana Budny Niero; Laíse Dimer Sant'ana da Rosa; Vanilde Citadini-Zanette; Guilherme Alves Elias; Patrícia de Aguiar Amaral
Journal:  J Public Health Res       Date:  2022-08-30

5.  Triatomine Fauna and Recent Epidemiological Dynamics of Chagas Disease in an Endemic Area of Northeast Brazil.

Authors:  Cláudia M Melo; Ana Carla F G Cruz; Antônio Fernando V A Lima; Luan R Silva; Rubens R Madi; Veronica de Lourdes S Jeraldo; Ruben Mercado
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-10-01       Impact factor: 2.471

6.  Human visceral leishmaniasis and relationship with vector and canine control measures.

Authors:  Danielle Nunes Carneiro Castro Costa; Patricia Marques Moralejo Bermudi; Lilian Aparecida Colebrusco Rodas; Caris Maroni Nunes; Roberto Mitsuyoshi Hiramoto; José Eduardo Tolezano; Rafael Silva Cipriano; Graziela Cândido Diniz Cardoso; Cláudia Torres Codeço; Francisco Chiaravalloti Neto
Journal:  Rev Saude Publica       Date:  2018-11-23       Impact factor: 2.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.